The BSE Sensex closed at 74,683.70 on April 9, down 58.80 points, or 0.08 percent. The index peaked at 75,124.28, the highest point in history. The NSE Nifty finished at 22,642.75, down 0.10 percent. During yesterday’s trading, the index also reached a new high of 22,768.40.
The Nifty Bank index, which is based on data from 12 banking companies, finished higher at 48,730.55, up 148.85 points, or 0.31 percent, from its previous high of 48,960.75.
As to Zee Business & Experts, today’s attention will be on the stocks listed below.
Paytm: The company’s MD and CEO, Surinder Chawla, resigned on June 26. This will bring attention to the stock once again today.
Lupin: The United States Food and Drug Administration (U.S. FDA) gave the business permission to introduce Doxycycline Capsules, 40 mg, as the first generic version of Oracea in the country.
Krystal Integrated Services: On Wednesday, the business will release its Q4FY24 financial results.
Aegis Logistics: On April 10, the board of the firm will talk about dividends.
Interglobe Aviation: Recently, there has been a 20–25% rise in airfare. Prices rose as a result of the Vistara flight issue and the strong demand for air travel.
Protean eGov: In a block sale expected to be valued at Rs 245 crore, 360 ONE Funds will sell 21.5 lakh shares in the firm.
Lupin: After receiving permission from the USFDA, the business introduced the Doxycycline capsule, which is used to treat inflammatory lesions.
Finolex Industries: The business sold the Adani Group land for Rs 471 crore.
IRB Infra: The Arbitral Tribunal denied IRB Ahmedabad’s 1032 crore claim from NHAI.
Axis Bank: Mirae Asset MF and Goldman Sachs purchased the bank after the PE investor sold their interest in the business.
Five Star Business: TPG Asia VII SF sold 56.54 lakh (1.9%) shares of the firm in bulk at an average price of Rs 752.02 per share.
Vedanta: CLSA raised the company’s rating from the previous underperformance call to “buy,” with a target price of Rs 390 per share.
Godrej Properties: Jefferies maintained its buy recommendation on the business and raised its target price per share from Rs 2700 to Rs 3175.